U.S. Markets open in 4 hrs 17 mins

AMAG Pharmaceuticals, Inc. (AMAG)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
17.15+0.20 (+1.18%)
At close: 4:00PM EDT
People also watch
ACORALNYAKRXMNTAANAC
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Revenue12/31/201612/31/201512/31/2014
Total Revenue532,091418,276124,384
Cost of Revenue116,88988,50120,306
Gross Profit415,202329,775104,078
Operating Expenses
Research Development66,08442,87824,160
Selling General and Administrative249,870160,30972,254
Non Recurring20,37815,36811,501
Others---
Total Operating Expenses---
Operating Income or Loss78,870111,220-3,837
Income from Continuing Operations
Total Other Income/Expenses Net3,338-18,1251,192
Earnings Before Interest and Taxes82,20893,095-2,645
Interest Expense73,15353,25114,697
Income Before Tax9,05539,844-17,342
Income Tax Expense11,5387,065-153,159
Minority Interest---
Net Income From Continuing Ops-2,48332,779135,817
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-2,48332,779135,817
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-2,48332,779135,817